Terns Pharmaceuticals, Inc.TERNNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank71
3Y CAGR+12.0%
5Y CAGR+28.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+12.0%/yr
vs +54.8%/yr prior
5Y CAGR
+28.5%/yr
Recent deceleration
Acceleration
-42.8pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
3.5x
Strong expansion
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$31.48M-0.9%
2024$31.76M-18.7%
2023$39.06M+74.3%
2022$22.41M+14.6%
2021$19.55M+117.3%
2020$9.00M+3.8%
2019$8.66M+122.1%
2018$3.90M-